Submit Deal

Submit Deal

Cover Image Marc Dunoyer

Marc Dunoyer

CEO at ALEXION PHARMACEUTICALS INC

Manager

Deal Bio

Total Deals5

Valued Deals5

Total Value£ 35.80 B

Avg. Deal Size£ 7.16 B

Market Context

Sort

28 Mar 2019|Japan|Pharmaceuticals

Target: DAIICHI SANKYO (TRASTUZUMAB DERUXTECAN)

Bidder: ASTRAZENECA PLC

3 Service Providers

2 Bidder | 1 Vendor

11 Dealmakers

5 Bidder | 6 Vendor

£ 5.26 B

Value

12 Dec 2020|United States|Biotechnology

Target: ALEXION PHARMACEUTICALS INC

Bidder: ASTRAZENECA PLC

20 Service Providers

6 Target | 14 Bidder

63 Dealmakers

37 Target | 26 Bidder

£ 29.44 B

Value

29 Sep 2021|United States|Biotechnology

Target: CAELUM BIOSCIENCES

Bidder: ASTRAZENECA PLC

6 Service Providers

2 Target | 2 Bidder | 2 Vendor

10 Dealmakers

4 Target | 3 Bidder | 3 Vendor

£ 257 M

Value

03 Oct 2022|United States|Biotechnology

Target: LOGICBIO THERAPEUTICS

Bidder: ALEXION PHARMACEUTICALS INC

6 Service Providers

3 Target | 3 Bidder

48 Dealmakers

23 Target | 25 Bidder

£ 60 M

Value

28 Jul 2023|United States|Biotechnology

Target: PFIZER (PRECLINICAL GENE THERAPY PROGRAMS)

Bidder: ALEXION PHARMACEUTICALS INC

5 Service Providers

3 Bidder | 2 Vendor

14 Dealmakers

10 Bidder | 4 Vendor

£ 779 M

Value

Privacy Policy Terms of Service Contact Us Cookie Preferences

All rights reserved. Copyright © 2025 Datasite